Developing traditional chinese medicine in the era of evidence-based medicine: current evidences and challenges.
Developing traditional chinese medicine in the era of evidence-based medicine: current evidences and challenges.
复制标题
DOI：
10.1155/2015/425037
复制
发表时间：
2015
期刊：
影响因子：
--
通讯作者：
Linn YC
中科院分区：
文献类型：
--
作者：
Fung FY;Linn YC
循证医学（EBM）通过将个人临床专业知识与来自系统研究的最佳临床证据相结合，近年来已被确立为现代医疗实践的标准，以提高治疗效果和安全性。另一方面，中国传统医学（TCM）是2000多年前从古代中国发展而来的一种医学实践体系，其基础是经验知识、理论和概念，而这些理论和概念尚未被科学的对等物所描绘出来。尽管中医药的使用不断扩大，其治疗效果在世界范围内得到了认可，但缺乏来自循证医学角度的有力证据，阻碍了西医对中医药的接受，阻碍了中医融入主流医疗保健。为了使中医成为医疗保健系统的一个组成部分，从而合理地利用其益处，为患者带来最大利益，中医必须根据循证医学的高水平证据证明其有效性和安全性，尽管在将循证医学模型应用于这一传统做法的有效性和可行性方面仍存在许多争议。本文旨在讨论中医的研究现状，探讨其有效性和安全性的现有证据，并强调中医应用EBM面临的问题和挑战。
Evidence-based medicine (EBM), by integrating individual clinical expertise with the best available clinical evidence from systematic research, has in recent years been established as the standard of modern medical practice for greater treatment efficacy and safety. Traditional Chinese Medicine (TCM), on the other hand, evolved as a system of medical practice from ancient China more than 2000 years ago based on empirical knowledge as well as theories and concepts which are yet to be mapped by scientific equivalents. Despite the expanding TCM usage and the recognition of its therapeutic benefits worldwide, the lack of robust evidence from the EBM perspective is hindering acceptance of TCM by the Western medicine community and its integration into mainstream healthcare. For TCM to become an integral component of the healthcare system so that its benefits can be rationally harnessed in the best interests of patients, it is essential for TCM to demonstrate its efficacy and safety by high-level evidence in accordance with EBM, though much debate remains on the validity and feasibility of applying the EBM model on this traditional practice. This review aims to discuss the current status of research in TCM, explore the evidences available on its efficacy and safety, and highlight the issues and challenges faced in applying EBM to TCM.
登录
查看更多内容
影响因子：
8.4
作者：
Linde, Klaus;Allais, Gianni;Brinkhaus, Benno;Manheimer, Eric;Vickers, Andrew;White, Adrian R.
通讯作者：
White, Adrian R.
影响因子：
2.6
作者：
Hsieh, Shu-Ching;Lai, Jung-Nien;Wang, Jung-Der
通讯作者：
Wang, Jung-Der
影响因子：
8.3
作者：
Chen, Christopher L. H.;Venketasubramanian, Narayanaswamy;Bousser, Marie-Germaine
通讯作者：
Bousser, Marie-Germaine
影响因子：
8.3
作者：
Chen, Christopher L. H.;Young, Sherry H. Y.;Bousser, Marie-Germaine
通讯作者：
Bousser, Marie-Germaine
影响因子：
5.8
作者：
Lian, Fengmei;Li, Guangwei;Tong, Xiaolin
通讯作者：
Tong, Xiaolin